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Soybeans and soyfoods are rich in isoflavones. The importance of isoflavones is 
widely appreciated and is the subject of intense research and discussions. The most common 
isoflavones are genistin, genistein, daidzin, and daidzein. Genistein and daidzein are the non- 
glucoside forms of genistin and daidzin, respectively. The chemical structures of these non- 
glucoside forms are very similar to the human estrogen. In soybeans the concentrations of the 
glucoside forms of isoflavones are relatively higher than the corresponding non-glucoside 
compounds. When soyfoods are made, processing procedures can affect the concentrations of 
the isoflavones. 
The main objective of this study is to determine the effects of processing variables on 
concentrations of genistin, daidzin, genistein and daidzein in soymilk. The variables that were 
considered are type and pH of soaking solution, soaking temperature, grinding temperature, 
and addition of glucosidase enzyme. 
The three soaking solutions are water, hydrochloric acid (HCI), and acetic acid 
(HC2H302) solutions. The three soaking temperatures used are 5 "C, 21 "C, and 55 "C. The pH 
of HC1 and HC2H302 solutions are 2,4, and 6. The two grinding temperatures used are 21 "C 
and 80 "C. 
High-Performance-Liquid-Chromatography (HPLC) was used to determine isoflavone 
contents of soymilk samples. The data were analyzed using a statistical package called 
Statistical Product and Service Solutions (SPSS). Statistical analysis was conducted to evaluate 
correlations between processing variables and the concentrations of isoflavones in soymilk. In 
addition, pair-sample t-test was conducted to evaluate whether or not there are differences in 
the means of isoflavone concentrations in soymilk treated with and without glucosidase 
enzyme. 
The major findings of this study are: the pH of HC2H302 solution significantly 
affected the yield of genistein (p < 0.05). A negative correlation was found between soaking 
temperature and the concentrations of genistin and daidzein in soymilk made from beans that 
were soaked in water (p < 0.05). There were strong correlations between grinding temperature 
and the concentrations of genistein, daidzin, daidzein (p < 0.01), and genistin (p < 0.05) in 
soymilk made from beans that were soaked in HC1 solution. The results of pair-sample t-test 
showed that the addition of glucosidase enzyme significantly increased the yield of the four 
isoflavones in soymilk. 
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CHAPTER ONE 
INTRODUCTION 
Public awareness and interest in healthy living and good nutrition have increase 
significantly in the past 20 years. From 1975 to 1985, there was about a threefold 
increase in awareness of the relation between salt and high blood pressure, and public 
knowledge of the link between saturated fat and heart disease has doubled (McGinnis & 
Ernst, 2001). In 1999, the Food and Drug Administration (FDA) approveda health claim 
for the cholesterol-lowering properties of soy protein (FDA, 1999). The health claim is 
that, diets low in saturated fat and cholesterol that include 25 grams of soy protein a day 
may reduce the risk of heart disease (FDA, 1999). A year later, the American Heart 
Association (AHA) revised dietary guidelines (Krauss et al., 2000). The revised dietary 
guidelines provide population-wide recommendations for cardiovascular disease 
prevention and treatment that are supported by decades of research (2000). The 
recommendations are based on an overall balanced and nutritious dietary pattern. 
Even though increasing public awareness of the importance of good nutrition 
through governmental founded programs and technologically advanced medical care, 
significant health problems still exist in the United States. According to the World Health 
Organization's compilation of cancer data fiom 45 countries around the world collected 
from 1994 to 1997, the incidence of cancer in females in the United States was ranked 7th 
in the world, whereas China was ranked 37" and Japan was ranked 42nd. The United 
States was ranked in female breast cancer incidence, whereas Japan was ranked 43rd 
and China was ranked 4Ith. In 2001, data show that 700,142 Americans died of heart 
diseases and 553,768 Americans died of cancers (Cancer statistics, 2004). Currently, the 
top five causes of death in United Stated are heart disease, cancer, cerebrovascular 
disease, chronic lung diseases, and accidents (McGinnis & Ernst, 2001). Almost 70% of 
all deaths in United States are from heart disease, cancer, and stroke (2001). McGinnis 
and Foege reported that 20 - 33% of cardiovascular deaths, 20 - 60% of fatal cancers, and 
50 - 80% of diabetes mellitus cases are associated with dietary factors or sedentary 
lifestyles (McGinnis & Foege, 1993). Over the past years, increasing evidence suggests 
that dietary consumption of fruits and vegetables may help reduce the incidence of 
several chronic diseases (Fournier et al, 2001). Soybeans, in particular, have been 
recognized as having a potential role in the prevention and treatment of osteoporosis, 
cardiovascular disease, and hormone-dependent cancers (Miller, 1990). 
Diets high in animal fat and red meat are associated with an increased risk of 
cancer and other chronic diseases (Miller et al. 1994). Differences in the incidence of 
cancer in Asian and American cultures may be due to fundamental differences in diet 
(Garlock, 2000). Americans consume a typical Western diet consisting of high-fat foods 
while those in Asian cultures typically consume a low-fat diet (Garlock, 2000). 
Consumption of soy products such as tofu, miso, and tempeh is common in Asian 
cultures (Garlock, 2000). According to Fournier et al. (2001), countries with high daily 
intakes of soy products have the lowest incidence rates of hormone-dependent cancers. 
Figure 1 shows daily soy product consumption by country (Fournier et al., 2001). 
With the increased emphasis on healthy diets, soy consumption in United States 
has changed. This change was presented by increased sales of soy products in the United 
States. According to FDA data, U.S. retail sales of soyfoods were $852 million in 1992 
and were projected to rise to $3.714 billion in 2002 (Henkel, 2000). Figure 2 shows retail 
sales of soyfoods in the United States (Henkel, 2000). 
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Figure I .  Daily soy product consumption in glday by country 
Source: Foumier et al., 2001 
Figure 2. U.S.  retail sales of soyfoods in billion dollars from 1992 to 2002 
Source: Henkel, 2000 
Soybeans contain a group of compounds called isoflavones. Isoflavones are 
categorized as phytoestrogens (Knight & Eden, 1994). Phytoestrogens occur naturally in 
many plants and have structural and functional similarities to the human estrogen, 
17P - estradiol(1994). Increasing evidence has indicated that isoflavones in soybeans 
have potential benefits on human health, particularly to several chronic diseases such as 
osteoporosis, cardiovascular disease, breast cancer, and prostate cancer (Potter et al., 
1998; Alekel et al., 2000; Nagata et al., 1998; Tonstad et al., 2002; Dai et al., 2001; 
Kolonel et al., 2000; & Lee et al., 2003). 
The most common isoflavones are genistin, genistein, daidzin, and daidzein. 
Genistein and daidzein are the non-glucoside forms of genistin and daidzin, respectively. 
The concentrations of the glucoside forms of isoflavones are relatively higher than the 
corresponding non-glucoside compounds in soybeans. The effects of soybean processing 
techniques on the contents of isoflavones have been investigated (Wang & Murphy, 1996; 
Grun et al., 2001; & Eisen et al., 2003). According to Wang and Murphy (1996), soaking 
and heat processing in tempeh production significantly reduces the isoflavones by 12% 
and 49%, respectively. In tofh production the process of coagulation causes 44% loss of 
isoflavones. The alkaline extraction process causes 53% loss of isoflavones in soy protein. 
The objectives of this study are, to investigate the effects of type and pH of 
soaking solution, soaking temperature, grinding temperature, and addition of glucosidase 
enzyme on concentrations of isoflavones in producing soymilk. The three soaking 
solutions are water, hydrochloric acid (HC1) solution, and acetic acid (HC2H302) solution. 
The pH of HC1 and HC2H302 solutions are adjusted at three different levels of 2,4, and 6. 
The three soaking temperatures are 5 "C, 21 "C, and 55 "C. The two grinding 
temperatures are 21 "C and 80 "C. 
Specific Aims 
This research study is to perform statistical analysis on the data generated in 
Dr. Ana M.Q. VandeLinde's laboratory. There are four research questions that this study 
attempts to answer: 
A. Is there any significant correlation between pH of HCI and HC2H302 solutions and 
concentrations of isoflavones in soymilk? 
B. Is there any significant correlation between soaking temperature and concentrations of 
isoflavones in soymilk made fkom soybeans that are soaked in water, HCl, and HC2H302 
solutions? 
C. Is there any significant correlation between grinding temperature and concentrations of 
isoflavones in soymilk made from beans that are soaked in water, HC1, and HC2H302 
solutions? 
D. How does the addition of glucosidase enzyme affect the concentrations of isoflavones 
during the production of soymilk? 
CHAPTER TWO 
LITERATURE REVIEW 
This chapter begins with a discussion of the different forms of isoflavones, their 
consumption, absorption, and metabolism. Studies of the effects of soy isoflavones on 
human health are then discussed with emphasis on certain selected chronic diseases 
including osteoporosis, cardiovascular disease, breast cancer, and prostate cancer. 
Background on Soy Isojlavones 
Isoflavones are groups of compounds found in a variety of grains, legumes, and 
vegetables. In particular, legumes such as soybeans provide the most abundant source of 
isoflavones (Munro et al., 2003). Soy isoflavones are considered as phytoestrogens. 
Phytoestrogens are plant-derived estrogens that may have estrogenic or anti-estrogenic 
effects. These phytoestrogens offer potential alternative therapies for a range of hormone- 
dependent diseases including breast cancer, prostate cancer, osteoporosis, and 
cardiovascular diseases (Setchell & Cassidy, 1999). 
Isoflavones exist in two forms. One form contains glucose and the other form 
called aglycones does not contain glucose. The glycone form of the isoflavones is 
biologically active. The three most common isoflavone aglycones in soybeans are 
genistein, daidzein, and glycitein. These are the aglycone of genistin, daidzin, and 
glycitin, respectively. In soybean, the glycoside forms are present in higher concentration 
than the aglycone forms (Naim et al., 1974). When the glycosides are esterified with 
either malonyl or acetic acid, 12 different isoflavones are formed. Figure 3 shows the 
chemical structures of these isoflavones (Messina, M.J. & Messina, V., 2003). 
Figure 3. Chemical structures of common isoflavones. 
Source: Messina, M.J. & Messina, V., 2003 
Of all the plants investigated, soybeans contain the highest concentration of 
isoflavones. The concentration of isoflavones in soybeans varies with the variety of 
soybeans, geographic location, soil type, crop year, and environmental growing 
conditions (Wang & Murphy, 1994). In addition, processing of soybeans either at home 
or within the food industry affects the concentration of isoflavones in soy products 
(Reinli & Block, 1996). Zhou and Erdman (1997) indicated that processing of soybeans 
for the manufacturing soy-containing food products increases hydrolysis of isoflavone 
glucosides, resulting in higher concentrations of the aglycones. 
Products Containing Soybeans 
In general, soyfoods can be divided into two categories: fermented soyfoods and 
non-fermented soyfoods. Fermented soyfoods include miso, tempeh, shoyu or soy sauce, 
and natto; soymilk and tofu are non-fermented soyfoods. According to Hutchins and 
colleagues (1 995), the fermented soyfoods contain proportionally higher concentrations 
of aglycone forms of isoflavones because fermentation partially hydrolyzes isoflavone 
glucosides. 
There are five commonly consumed soyfoods in America (Munro et al., 2003). 
The most commonly consumed soyfood is soymilk. Soymilk can be processed from 
whole soybeans or full-fat soy flour (Smith, 1978). Traditionally soymilk is made from 
good quality whole soybeans. The beans are thoroughly washed and soaked in water for 
several hours depending on the temperature of the water. The beans are then ground with 
the addition of enough water to give the desired slurry. The slurry is heated at near 
boiling for 15 to 20 minutes. The warm slurry is then filtered to remove the insoluble 
residue. The milky liquid is soymilk. Soymilk can adapt to any recipe. The plain, less 
sweet soymilk works best for sauces, gravies, and soups. One cup of plain-unfortified 
soymilk contains 80 calories and seven grams of protein. One cup of fortified soymilk 
contains 130 calories and 10 grams of protein (Soyfood facts, n.d.). The nutrition facts of 
soymilk are listed in Table 1 (Soyfood facts, n.d.). 
Tofu is the second common consumed soyfood in America (Munro et al., 2003). 
Tofu is made by precipitating the protein called curd from soymilk. Coagulants such as 
calcium sulfate are used to form the curd. The curd then is pressed to release amber liquid 
called whey. 
Table 1 
Nutrition facts of soymilk, tofu, miso, and tempeh 
Source: www. soyfoods.org/facts/facts.html (Retrieved November 12,2004) 
Calories 
Total fat (g) 
Saturated fat (g) 
Total 
carbohydrates 
(g) 
Protein (g) 
Cholesterol 
(mg) 
Sodium (mg) 
Dietary fiber (g) 
Calcium (mg) 
Potassium (mg) 
Phosphorus 
(mi?) 
Folate (mcg) 
Fortified 
soyrnilk 
(1 cuplserving) 
130 
----- 
4 
0.5 
13 
10 
0 
105 
0 
200 
p---p. 
440 
150 
4 
Unfortified 
soymilk 
(1 cuplserving) 
8 0 
4 
0.5 
4 
7 
0 
39 
3 
10 
345 
129 
4 
Tofu 
(% cuplserving) 
97 
6 
0.8 
4 
10 
10 
10 
0 
204 
222 
185 
42 
Miso Tempeh 
(1 Tbslserving) (%cup/serving) 
35 
1 
0.5 
5 
2 
0 
626 
1 
11 
2 8 
26 
6 
6 
1 
14 
16 
10 
5 
7 
77 
305 
17 1 
43 
The firmness of tofu changes depending on the type of coagulants, the amount of 
coagulants, and the amount of whey removed (Tofu, n.d.). Half a cup of tofu contains 97 
calories and 10 grams of protein (Table 1). 
Miso is made from soybeans, salt, water, and koji. Koji is a microorganism that 
are used to trigger fermentation. Rice or barley can also be used to make miso. The 
common use of miso is to enhance the flavor of soups, dips, and dressings. The color and 
the flavor of miso vary wisely depending on the proportion of salt added to soybeans, the 
addition of rice or barley, and the length of fermentation (Miso, n.d.). For example, the 
higher the ratio of rice to soybeans, the lighter the color of miso and the sweeter the miso. 
The longer the fermentation period, the better the flavor of miso (Smith, 1978). One table 
spoon of miso contains 35 calories and two grams of protein (Table 1). 
Tempeh is a very popular Indonesian soyfood that undergoes a sequence of 
soaking, cooking, inoculation, and fermentation of soybeans (Garlok, 2000). Rhizopus 
oligosporus is the mold responsible for tempeh fermentation (2000). During incubation, 
Rhizopus oligosporus produces a white mycelium throughout the soy grits, resulting in a 
formed, unified, white tempeh cake (2000). Tempeh is also a good source of dietary fiber 
and soy protein. Half a cup of tempeh contains 165 calories, 16 grams of protein, and 
seven grams of dietary fiber (Table 1). 
In 1999, researchers at the US Department of Agriculture (USDA) and Iowa State 
University have created an online database that lists the isoflavone content of foods 
(USDA, 2002). Table 2 summarizes the isoflavone content of selected soyfoods (Messina, 
M.J. & Messina, V., 2003). 
Table 2 
Isofavone, protein, and energy content of selected soyfoods 
Source: Messina, M.J. & Messina, V., 2003 
Food (USDA* No.) 
Tofu, firm (1 6 126) 
Tofu, regular (1 6427) 
Silken, firm (1 6 162) 
Natto (161 13) 
Soymilk (1 6 120) 
Miso (161 12) 
Protein11 OOg 
8.0 
8.1 
6.9 
17.7 
2.8 
11.8 
Isoflavones 
(~g /g)  
247 
236 
279 
589 
97 
426 
Tempeh (161 14) 
Soynuts, dry roasted (161 11) 
-
Soyflour, defatted (1 6 1 17) 
Kcalll OOg 
77 
76 
62 
2 12 
33 
206 
Soyflour, full fat (1 6 1 15) 
Soybeans, raw (16 108) 
Soybeans, cooked (1 6 109) 
Isoflavone/Protein 
(mg/g) 
3.1 
2.9 
4.0 
3.3 
3.5 
3.6 
1779 
1284 
547 
34.5 
36.5 
16.6 
43 6 
416 
173 
5.2 
3.5 
3.3 
Absorption and Metabolism of Isoflavones 
The chemical form of isoflavones and their metabolites may influence the extent 
of their intestinal absorption. Research indicates that the aglycone forms of isoflavones 
are more readily absorbed and more bioavailable than its glycoside forms (Setchell, 2000; 
Izumi et al., 2000). It has also been reported that intestinal microflora plays a key role in 
the metabolism and bioavailability of isoflavones (Borriello et al., 1985; Setchell et al., 
1984). 
After ingestion, soy isoflavones are hydrolyzed in the large intestine by intestinal 
glycosidases, resulting in the removal of the sugar moiety to release their aglycones, 
daidzein, genistein, and glycitein (Izumi et al., 2000). Following absorption of the 
aglycones, these compounds and their metabolites are readily conjugated in the liver with 
glucuronic acid and/or sulfate, and then circulated enterohepatically with potential 
metabolism and reabsorption in the intestine. Conjugated aglycones of isoflavones are 
excreted predominantly in the urine (Munro et al., 2003). Any isoflavones that are not 
absorbed in the intestine are excreted in an unconjugated form in feces (Adlercreutz et al., 
1995). Daidzein may be further metabolized by resident microflora in the gastrointestinal 
tract to equol and 0-desmethylangolensin. Similarly, genistein may be metabolized to 
6'-hydroxy- 0-desmethylangolensin (Munro et al., 2003). Figure 4 and Figure 5 show the 
metabolism of daidzein and genistein, respectively (2003). 
OH 
Oaidzein 
J 
HO HO q"b 0 
' OH OH 
Ditrydrodaldzein Oehydroequol 
HQ 
OH OH 
Q-Desmethylangolensin Equal 
Figure 4. The metabolism of daidzein. 
Source: Munro et al., 2003 
Figure 5. The metabolism of genistein. 
Source: Munro et al., 2003 
The absorption, distribution, and excretion (ADE) of soy isoflavones may be 
influenced by an individual's age, gender, and cultural group. Interindividual variability 
has been showed in some studies (Xu et al., 1995; Morton et al. 1997; Xu et al., 2000). 
Lu and Anderson (1 998) investigated the ADE of isoflavones between males and females 
and found inconsistent results. Hendrich et al. (1999) suggested that metabolic 
diffferences may be attributed to differences in the subpopulation's microflora, intestinal 
transit time, pH, or redoxpotential in the intestines of research subjects. Other factors 
such as diet, surgery, medication, bowel disease, and host immunity may also influence 
isoflavone metabolism (Knight & Eden, 1995). 
Effects of Isoflavones on Human Health 
Bone Health and Osteoporosis 
The development of osteoporosis is a major concern for postmenopausal women. 
The decreased availability of estrogen among postmenopausal women are believed to be 
a cause of accelerated bone loss and the increased susceptibility to develop osteoporosis 
(Goldwyn et al., 2000). Hormone replacement therapy is the treatment of choice for 
postmenopausal women suffering from a reduction in bone mass (Goldwyn et al. 2000). 
Although the mechanisms are not entirely clear, it has been proposed that estrogen (a) 
reduces the sensitivity of bone tissue to the resorptive effects of parathyroid hormone; (b) 
blocks the release of interleukin- 1, a potent bone resorption agent; andlor (c) directly 
modulates osteoblast activity (Kurzer & Xu, 1997). 
Ipriflavone is a synthetic isoflavone lacking estrogenic activity but is strikingly 
similar in chemical structure to daidzein and genistein (Setchell & Cassidy, 1999). 
Ipriflavone is approved as an alternative to hormone replacement therapy for preventing 
bone loss in estrogen-deficient conditions (Setchell & Cassidy, 1999). Unfortunately, 
hormone replacement therapy may have long-term negative effects that include an 
increased risk of breast cancer and of developing thromboembolisms (Goldwyn et al., 
2000). This led researchers to investigate the effects of isoflavones on preventing bone- 
related diseases such as osteoporosis. 
In 1998, Potter et al. investigated the effects of soy isoflavones on bone mineral 
density (BMD) and bone mineral content (BMC) in the lumbar spine among 66 
postmenpausal women ages 41 to 83 years. All the subjects were randomly assigned to 
three dietary groups: the control group had a diet with 40 grams of protein obtained from 
casein and nonfat dry milk daily; the ISP56 group had a diet with 40 grams of isolated 
soy protein containing 56 milligrams of isoflavones daily; and the ISP90 group had a diet 
with 40 grams of isolated soy protein containing 90 milligrams of isoflavones daily. 
Potter and colleagues (1998) reported that after six months of treatment, the bone mineral 
density and content in the lumbar spine in the subjects of ISP90 group increased 
significantly compared with the subjects belonging to the control group. They also found 
that the ratio of total cholesterol to high density lipoprotein (HDL) cholesterol was 
improved with respect to cardiovascular risk in the subjects of both ISP56 and ISP90 
groups. The results from this study indicated that soy protein at both isoflavone 
concentrations was effective in modulating the risks of both cardiovascular disease and 
osteoporosis in postmenopausal women (1 998). 
In another similarly designed study, Alekel et al. (2000) examined the effect of 
soy protein with isoflavones on BMD and BMC in lumbar spine among 69 
perimenopausal women. All the subjects were randomly assigned to three dietary groups. 
The control group had a diet containing 40 grams of whey protein daily, the SP+ group 
had a diet with soy protein containing 80.4 milligrams of isoflavones daily, and the SP- 
group had a diet with soy protein containing 4.4 milligrams of isoflavones daily. The 
results of this study found that the SP+ diet had a significantly positive effect on both 
BMD and BMC in lumbar spine, compared with both SP- and control groups. There was 
no effect on spinal loss in the subjects of both SP- and control groups. This study 
suggested that soy products containing isoflavones could serve as an alternative or 
adjunct treatment for women at risk of osteoporosis, especially for women who are poor 
candidate for hormone replacement therapy. 
Two long-term studies have been conducted on the effects of isoflavones in 
postmenopausal women (Vitolins et al., 2002; Lydeking-Olsen et al., 2002). Both studies 
were conducted for a period of two years. In the study of Vitolins et al. (2002), the base 
diet supplied 25 g of soy protein daily as recommended by the Food and Drug 
Administration (FDA, 1999). The 25 g of soy protein base diet was supplemented with 
three different levels of isoflavones: 5 mg/day, 42 mg/day, and 58 mg/day. The results 
showed that there was no difference on the total body BMD in total body among the three 
groups. By contrast, Lydeking-Olsen et al. (2002) found that the BMD and the BMC in 
lumbar spine increased 1.1% and 2.2% respectively in subjects who consumed 500 mL 
soymilk supplemented with 85 mg of isoflavones per day. For the subjects of another 
group who consumed the same amount of soymilk with less than 1 mg isoflavone per day, 
the BMD and BMC in lumbar spine decreased by 4.2% and 4.3%, respectively. The 
results from both studies revealed somewhat conflicting data with regard to the effect of 
isoflavones (Setchell & Lydeking-Olsen, 2003). Setchell and Lydeking-Olsen (2003) 
indicated that more long-term studies are needed before definitive conclusions can be 
reached regarding the effectiveness of phytoestrogens on bone health. 
Cardiovascular Diseases 
Cardiovascular disease is a broad term used to describe many different conditions 
of the heart. Preventing or reducing the increase in serum cholesterol is associated with a 
decreased risk for cardiovascular disease (Setchell & Cassisy, 1999). In 1999, the U.S. 
Food and Drug Administration approved a health claim that diets low in saturated fat and 
cholesterol (that include 25 grams of soy protein a day) may reduce the risk of heart 
disease (FDA, 1999). 
The exact mechanism underlying the hypocholesterolemic effect of soy protein 
remains intangible and is almost certain to be multifactorial (Setchell & Cassisy, 1999). 
Consumption of soy products has the effect of increasing fecal bile acid excretion and 
altering the rate of synthesis of bile acids, one of the primary mechanisms responsible for 
the regulation of cholesterol homeostasis (1999). Moreover, lipoprotein metabolism is 
influenced by estrogenic hormones (1 999). Soy isoflavones may influence lipoprotein 
metabolism by upregulating low density lipoprotein (LDL) receptor activity (1999). 
Nagata et al. (1 998) reported a relationship between soy product intake and serum 
total cholesterol concentration in 1,242 men and 3,596 women in Japan. They reported a 
strong inverse relationship between serum cholesterol and daily intake of soy products in 
men and women after controlling for age, smoking status and intake of total energy, total 
protein and total fat. 
In another study, Jenkins et al. (2002) reported the effects of three diets on several 
parameters associated with cardiovascular health. Thirty seven healthy hyperlipidemic 
men and 36 postmenopausal women participated in this study. The parameters that they 
observed were total cholesterol, estimated coronary artery disease (CAD) risk, ratio of 
total cholesterol to HDL cholesterol, and ratio of LDL cholesterol to HDL cholesterol. 
Each participant was assigned to three different groups. The control group was given 
daily a low fat dairy diet. The second group was given daily a high isoflavone soyfood 
diet containing 50 g soy protein. This diet contains 73 mg isoflavones. The third group 
was given daily a low isoflavone soyfood diet containing 52 g soy protein which has 10 
mg isoflavones. No significant differences were found among participants in the high-and 
low-isoflavone soy diets. Compared with the control group, however, both soy groups 
resulted in significantly lower total cholesterol, estimated CAD risk, ratio of total 
cholesterol to HDL cholesterol, and ratio of LDL to HDL cholesterol. The results 
suggested that substitution of soyfoods, regardless of isoflavone concentration, may 
improve many lipid and non-lipid risk factors for CAD and thus justify the use of 
soyfoods as part of a dietary strategy to reduce CAD risk. 
Tonstad et al. (2002) studied the effect of soy protein on serum lipid, lipoprotein, 
and homocysteine concentrations in 130 men and women who had initial LDL 
cholesterol concentrations greater than or equal to 4 mmoVL. Participants consumed 
either 30 grams or 50 grams of isolated soy protein daily as a beverage for 16 weeks. 
Equivalent grams of casein were also given to the participants in the control groups. 
Their results showed that in both soy protein groups, LDL cholesterol concentrations 
were significantly reduced without increasing lipoprotein concentrations when compared 
with both control groups. 
Breast Cancer 
Interest in research on the relationship between soy intake and risk of breast 
cancer was stimulated by the observation that relatively low breast cancer mortality rates 
are observed in women living in Asian countries where soyfoods are commonly 
consumed (Messina, 1999). In Japan for example, the breast cancer mortality rate is only 
about one-quarter of that in the United States (1999). Almost a decade earlier Barnes 
et al. (1990) reported potential antiestrogenic effects of soy isoflavones in mice. Their 
study showed that the soy isoflavones reduced the number of 7, 12-dimethylbenz (a) 
anthracene-induced mammary tumors. These early observations provided the basis for 
the hypothesis that soy intake decreases breast cancer risk. Since then numerous 
epidemiologic studies have examined the relation between soy intake and breast cancer 
risk (Greenstein et al., 1996; Dai et al., 2001; Shu et al., 2001; Wu et al., 2002; Keinan- 
Boker et al., 2004). 
The results of the Iowa Women's Study involving 34,000 women conducted by 
Greenstein et al. (1 996) found that, after eight years of follow up, tofu intake was 
associated with a modest decrease in breast cancer risk among postmenopausal women. 
The results, however, were not statistically significant. 
Dai and colleagues (2001) found an association between soyfood intake and 
breast cancer risk in a population-based case control study of Chinese women in 
Shanghai, China. This study used a food frequency questionnaire to obtain information. 
The results suggested that regular soyfood intake, particularly very high intake of 
soyfoods, may be associated with a reduced risk of breast cancer, especially among those 
individuals testing positive for the presence of both the estrogen receptor and the 
progesterone receptor (200 1). 
Results from two case control studies, one of Chinese women (Shu et al., 2001) 
and the other of Asian-American women (Wu et al., 2002) showed that women with 
higher intakes of soy isoflavones from soyfoods during their teen age years were 
significantly less likely to develop breast cancer later in life than those consuming diets 
lower in soy isoflavones. 
The inverse relationship between soy isoflavones and risk of breast cancer in 
women is not supported by all studies, however. The results of a recent large population 
study of Dutch women aged 49 to 70 years old conducted by Keinan-Boker et al. (2004) 
found that a high intake of isoflavones or mammalian lignans was not significantly 
related to breast cancer risk. According to the report of Messina & Loprinzi (2001), the 
research results attempting to show an association between soyfood intake and breast 
cancer risk are inconsistent, more epidemiologic studies may need to be considered. 
Prostate Cancer 
Prostate cancer is a hormone dependent cancer. This cancer is the second most 
common cancer in the United States (Goldwyn et al., 2000) and the sixth most common 
cause of cancer death (Messina, 2003). Prostate cancer mortality rates vary noticeably 
among countries. For example, prostate cancer mortality rates are three times higher in 
developed countries than in developing countries. Mortality rates are known to be 
especially low in Asia (2003). Biological mechanisms have been proposed that soy 
isoflavones have preventative roles in the development of prostate cancer that involves 
inhibition of angiogenesis, inhibition or stimulation of regulatory proteins in the cell cycle, 
and inhibition of a signal transduction pathway involving epidermal growth factor (Lee, 
et al., 2003). 
Results from three recent case-controlled studies using food frequency 
questionnaires to investigate the relationship between consumption of soy products and 
the incidence of developing prostate cancer have been equivocal because some results 
lack statistical significance (Strom, et al., 1999; Kolonel, et al. 2000; Lee, et al. 2003). In 
a study by Strom et al. (1999), 83 cases and 107 controls were examined. Cases involved 
patients treated at the University of Texas M.D. Anderson Cancer Center for prostate 
cancer diagnosed between January 1996 and February 1998. The controls were frequency 
matched to cases on age and race. The principal findings showed there were inverse 
relationships between genistein, daidzein and prostate cancer risks. The results of this 
study suggested that genistein and daidzein may reduce prostate cancer risks. 
Lee and colleagues (2003) observed the effect of soyfood consumption and two 
isoflavones (genistein and daidzein) on the risks of prostate cancer in 133 cases and 265 
age- and residential community-matched controls in China. Their results indicated 
reduced risks of prostate cancer associated with consumption of soyfoods and isoflavones. 
Interestingly, significant relationship was found in the subjects who consumed soyfoods 
and the isoflavone daidzein. 
In another multicenter case-control study by Kolonel et al. (2000), the relationship 
between vegetables, fruits, legumes and decreased risks of prostate cancer was examined 
among 1,6 19 cases and 1,6 18 controls involving African-American, White, Japanese, and 
Chinese men. Controls were frequency-matched to cases on the basis of ethnicity, age, 
and region of residence in a ratio of approximately 1 : 1. Some interesting findings were 
found in this study. First, there was little epidemiological evidence for a protective effect 
of fruits and tomatoes against prostate cancer. Second, the intake of yellow-orange 
vegetables such as carrots was inversely related to the risks of prostate cancer. Last, for 
all legumes including soyfoods, there was an inverse relationship between legumes 
consumption and the risks of prostate cancer with statistical significance in the African- 
American and Chinese men. Overall, these results suggest that legumes and certain types 
of vegetables may protect against development of prostate cancer. 
CHAPTER THREE 
METHODOLOGY 
This chapter includes information about the materials and reagents, the procedure 
for sample preparation, and the instrument used to generate data that are utilized in this 
study. The experimental data were provided by Dr. Ana M.Q. VandeLinde at the 
University of Wisconsin-Stout. The emphasis of this study is on the statistical analyses 
addressed of the data to address the research questions identified in Chapter one. 
Materials and Reagents 
All of the solvents, reagents, and isoflavones standards were purchased from 
either Sigma Chemical Co. (St. Louis, Mo) or Indofine Chemicals Inc. (Somerville, NJ). 
Milli-Q water, water filtered with a micropore filtering system, was used for the 
preparation of solvents and samples used in High-Performance-Liquid-Chromatograph 
(HPLC) analytical procedures. Soybeans were purchased from local supermarket. 
Soymilk Preparation 
A flow diagram for producing soymilk samples is shown in Figure 6 .  In the 
soaking process, soybeans were soaked until they weighed about 2.2 times the original 
weights at three different soaking temperatures and under three different acidic 
conditions. The three soaking temperatures used were 5 "C, 21 "C, and 55 "C. The three 
soaking solutions were water, hydrochloric acid (HCl) solution, and acetic acid 
(HC2H302) solution. The pH of HCl and HC2H302 solutions were adjusted at three 
different levels of 2,4, and 6 .  To make the slurry, water was added to the soaked 
soybeans until the weight was 3.5 times of the original weight of dried soybeans. Two 
different grinding temperatures used were 21 "C and 80 "C. In addition, glucosidase 
enzyme was added to the slurry of six soymilk samples to determine the effect of 
glucosidase enzyme on the concentrations of isoflavones in soymilk. A total of 35 
soymilk samples were analyzed in triplicates. Table 3 summarizes the different variables 
used in preparing the soymilk samples. 
I Grinding witldwithout ] 
\ 
glucosidase enzyme 
at21 "Cor80°C 
/ \ 
Cleaning raw soybeans 
\ / 
Insoluble residue 
Soaking with water or acidic 
solutions with various pH at 
5 "C, 21 "C, or 55 "C 
I Soyrnilk ] 
Figure 6. Flow diagram for production of soymilk 
Table 3 
Selected variables for producing soymilk samples 
Instrumentation 
High-Performance-Liquid-Chromatography (HPLC) was used to determine the 
isoflavone contents of soyrnilk samples by determining a linear relationship of 
concentration and peak areas of isoflavone standard solutions. The HPLC system was 
equipped with a MilliporeNaters model 710A WISP auto-injector and a 
MilliporeNaters model M6000A pump. The column Novapak C18 was purchased from 
Millipore Corporation (Milford, MA). The instrument conditions for detection of 
isoflavones at ambient temperature were: (a) mobile phase: methanol and 0.01M 
ammonium acetate buffer with pH 4.6, (b) flow rate at 0.40mL/minute, (c) injection 
volume of 15 mL, and (e) detection at 254 nm. HPLC procedure was conducted with a 
linear gradient from 25% to 60% methanol in 20 minutes, followed by an isocratic hold 
period of 25 minutes. Peak identification was carried using standard isoflavones: genistin, 
genistein, daidzin, and daidzein. Peak areas were converted into concentrations of these 
four isoflavones in milligrams per gram of dry soybean (mglg). Table 4 shows the means 
of concentrations of these four isoflavones in the soyrnilk samples. 
Grinding Temp ("C ) 
with or without 
glucosidase 
21,80 
21,80 
21,80 
Soaking Solution 
water 
HCl 
pH at 2,4, 6 
HC2H302 
pH at 2 , 4 , 6  
Soaking Temp ("C) 
5,21, 55 
5,21, 55 
5,21, 55 

Table 4 (continued) 
Soaking 
solution 
HC1 
HC1 
HC1 
HC1 
HC1 * 
(* one trial) 
HC1 
HC1 
Solution pH 
Soaking Temp. (OC) 
GrindingTemp.("C) 
6 
5 
2 1 
2 
2 1 
2 1 
4 
2 1 
2 1 
6 
2 1 
2 1 
2 
55 
2 1 
4 
55 
2 1 
6 
5 5 
2 1 
Genistin 
0.3702 * 0.01 12 
0.2144 * 0.0144 
0.3341 * 0.0196 
0.35 11 * 0.0087 
0.3502 
0.3718 * 0.0425 
0.3895 * 0.0214 
Genistein 
0.0857 * 0.0026 
0.2490 * 0.0106 
0.1966 * 0.01 19 
0.1 821 * 0.0020 
0.2633 
0.2316 * 0.0529 
0.1085 * 0.0173 
Daidzin 
0.1863 * 0.0053 
0.0913 * 0.0124 
0.1631 * 0.0130 
0.1696 * 0.0034 
0.1660 
0.1786 * 0.0267 
0.2370 * 0.0220 
Daidzein 
0.1017 * 0.0042 
0.0913 * 0.0106 
0.0160 * 0.0120 
0.0016 * 0.0006 
0.1293 
0.1015 * 0.0666 
0.0108 * 0.0153 
Table 4 (continued) 
Soaking 
solutuon 
HC1 
HCl 
HC1 
HC1 
glucosidase 
added 
HC1 
glucosidase 
added 
HC1 
glucosidase 
added 
HC2H302 
Solution pH 
Soaking Temp. ("C) 
Grinding Temp. ("C) 
2 
2 1 
8 0 
4 
2 1 
80 
6 
2 1 
80 
2 
2 1 
2 1 
4 
2 1 
2 1 
6 
2 1 
2 1 
2 
5 
2 1 
Genistin 
0.4074 * 0.0313 
0.3908 * 0.0251 
0.3925 * 0.0680 
0.41 83 * 0.0296 
0.4338 * 0.0178 
0.4573 * 0.0233 
0.2998 * 0.0281 
Genistein 
0.3284 * 0.0338 
0.0443 * 0.0102 
0.3996 * 0.1342 
0.2536 * 0.0078 
0.3 128 * 0.0052 
0.3481 h 0.0054 
0.1 125 * 0.0126 
Daidzin 
0.3038 * 0.0203 
0.3068 * 0.0145 
0.3099 * 0.0599 
0.3223 h 0.0205 
0.3043 * 0.01 04 
0.3201 * 0.01 12 
0.1342 * 0.0093 
Daidzein 
0.1767 * 0.0453 
0.1989 * 0.031 7 
0.2001 * 0.0613 
0.1293 * 0.022 1 
0.1977 * 0.0223 
0.2325 * 0.0224 
0.0826 h 0.0127 

Table 4 (continued) 
Soaking 
solution 
HC2H302 
HC2H302 
HC2H302 
HC2H302 
glucosidase 
added 
HC2H3 0 2  
glucosidase 
added 
Genis tin 
0.3238 * 0.1008 
0.3735 * 0.0239 
0.3561 * 0.0212 
0.4148 * 0.0103 
0.4205 * 0.0182 
Solution pH 
Soaking Temp. ("C) 
Grinding Temp. ("C) 
6 
5 5 
2 1 
4 
2 1 
80 
6 
2 1 
80 
4 
2 1 
2 1 
6 
2 1 
2 1 
- 
Genistein 
0.2498 * 0.0063 
0.341 1 * 0.0153 
0.1 175 * 0.0027 
0.3247 * 0.0089 
0.3223 * 0.0098 
Daidzin 
0.2058 * 0.0059 
0.2979 * 0.0092 
0.3247 * 0.0047 
0.3080 * 0.0080 
0.3201 * 0.0082 
Daidzein 
0.1065 * 0.0046 
0.1783 * 0.0140 
0.0869 * 0.0093 
0.1979 * 0.0298 
0.1788 * 0.0075 
Data Analysis 
The data were analyzed using a statistical package called Statistical Product and 
Service Solutions (SPSS). Statistical analysis was conducted to evaluate the following: 
(1) correlation between the pH of soaking solutions and the concentrations of isoflavones, 
(2) correlation between soaking temperature and the concentrations of isoflavones, and 
(3) correlation between grinding temperature and the concentrations of isoflavones. In 
addition, pair-sample t-test was conducted to evaluate whether or not there are 
differences in the means of isoflavone concentrations in soymilk treated with and without 
glucosidase enzyme. 
CHAPTER FOUR 
RESULTS AND CONCLUSIONS 
Table 5a to 5c show the means of isoflavone concentrations in soymilk made 
from beans that were soaked in water. Table 6a to 6c show the means of isoflavone 
concentrations in soymilk made from beans that were soaked in HCl solution. Table 7a to 
7c show the means of isoflavone concentrations in soymilk made from beans that were 
soaked in HC2H302 solution. 
Table 8 to 10 show the Pearson correlation results between the concentrations of 
isoflavones and the pH of soaking solutions, soaking temperature, and grinding 
temperature in soymilk. 
Table 11 shows the results of pair sample t-tests of the concentrations of 
isoflavones in soymilk samples made from the slurry that was treated with glucosidase 
enzyme and soymilk samples that were not treated with glucosidase enzyme (the other 
processing variables were held constantly). 
Table 5a 
Mean (* s, mg/g) concentrations of isofavons in soymilk madefrom beans soaked in 
water 
Table 5b 
Mean (* s, mg/g) concentrations of isofavons in soymilk madefrom beans soaked in 
water 
Table 5c 
Mean (* s, mg/g) concentrations of isofavons in soymilk madefrom beans soaked in 
water 
Daidzin 
0.2223 * 0.0689 
Genistein 
0.1569 * 0.0977 
N 
12 
Daidzein 
0.0950 h 0.0580 
Genistin 
0.3763 h 0.0455 
Soaking 
temperature 
("(3 
5 
2 1 
5 5 
Genistein 
0.1057 * 0.0006 
0.1650 k 0.1363 
0.1920 k 0.0044 
N 
3 
6 
3 
Grinding 
temperature 
("c) 
2 1 
8 0 
Daidzin 
0.1937 * 0.0060 
0.2832 * 0.0103 
0.1293 * 0.0223 
Genistin 
0.3765 * 0.0078 
0.4079 * 0.0243 
0.3 130 * 0.0291 
Genistin 
0.3718 * 0.0516 
0.3897 * 0.0198 
N 
9 
3 
Daidzein 
0.0870 * 0.0010 
0.1422 * 0.0147 
0.0087 * 0.0032 
Daidzein 
0.0817 h 0.061 1 
0.1350 h 0.0195 
Genistein 
0.1 128 * 0.0658 
0.2893 h 0.0075 
Daidzin 
0.2003 h 0.0656 
0.2883 h 0.0136 
Table 6a 
Mean (k s, mg/a) concentrations of isojlavons in soymilk made from beans soaked in HCl 
Table 6b 
Mean (k s, mg/g) concentrations of isojlavons in soymilk made from beans soaked in HCl 
Table 6c 
Mean (k s, mg/g) concentrations of isojlavons in soymilk made from beans soaked in HCl 
Genistein 
0.1777 0.1274 
0.2391 0.0699 
0.2012 * 0.1460 
Genistin 
0.3534 0.0882 
0.3536 0.0394 
0.3740 * 0.0364 
pH 
2 
4 
6 
N 
13 
12 
11 
Soaking 
temperature 
("c) 
5 
2 1 
5 5 
Daidzin 
0.2172 k 0.093 1 
0.1969 * 0.0691 
0.2242 * 0.0659 
Genistin 
0.3457 5 0.0261 
0.3486 * 0.0729 
0.3962 * 0.0436 
N 
9 
18 
9 
Daidzein 
0.1362 k 0.0458 
0.0883 0.0820 
0.0869 * 0.0873 
Genistein 
0.1202 0.0491 
0.2829 0.0952 
0.1353 k 0.1086 
Genistin 
0.3473 * 0.061 1 
0.3973 0.0402 
Genistein 
0.1547 * 0.0789 
0.3571 * 0.0765 
Grinding 
temperature 
("c) 
2 1 
80 
N 
27 
9 
Daidzin 
0.1689 k 0.023 1 
0.2237 k 0.0919 
0.2339 k 0.0646 
Daidzin 
0.18 13 0.0590 
0.3064 0.0324 
Daidzein 
0.0794 k 0.0359 
0.1 136 k 0.0902 
0.1 140 k 0.0694 
Daidzein 
0.0764 * 0.0592 
0.1914 0.0429 
Table 7a 
Mean (* s, mg/& concentrations of isofivons in soymilk made from beans soaked in 
Hc2H3 0 2  
Table 7b 
Mean (* s, mg/g) concentrations of isofivons in soymilk made from beans soaked in 
HC2H302 
Table 7c 
Mean (* s, mg/& concentrations of isofivons in soymilk made from beans soaked in 
Hc2H3 0 2  
Genistein 
0.0658 h 0.0512 
0.2078 h 0.0826 
0.2083 h 0.0647 
Genistin 
0.3 161 h 0.0255 
0.3622 h 0.0341 
0.3433 h 0.0495 
PH 
2 
4 
6 
N 
6 
12 
12 
Soaking 
temperature 
("c> 
5 
2 1 
5 5 
Daidzin 
0.1763 h 0.0472 
0.2345 h 0.0577 
0.221 8 h 0.0643 
Genistin 
0.3297 h 0.03 15 
0.3472 h 0.0237 
0.3647 h 0.0791 
N 
9 
15 
6 
Daidzein 
0.1322 h 0.0556 
0.0583 h 0.0731 
0.0803 h 0.0338 
Grinding 
temperature 
("c> 
2 1 
8 0 
Genistein 
0.1646 h 0.0495 
0.1829 k 0.1 164 
0.1940 k 0.0609 
Genistin 
0.3406 * 0.0449 
0.3648 * 0.0223 
N 
24 
6 
Daidzin 
0.1687 h 0.0296 
0.2379 h 0.0654 
0.2413 ;t 0.0428 
Genistein 
0.1673 * 0.0773 
0.2288 * 0.1229 
Daidzein 
0.0474 h 0.0367 
0.1 1 16 h 0.0642 
0.0592 ;t 0.0516 
Daidzin 
0.1945 * 0.0422 
0.3108 * 0.0158 
Daidzein 
0.0693 * 0.0577 
0.1322 * 0.0513 
Table 8 
Pearson correlation data of isoflavone concentrations in soymilk made from beans 
soaked in water 
* Correlation is significant at the 0.05 level (2-tailed). 
** Correlation is significant at the 0.01 level (2-tailed). 
N =  12 
Processing variables Genistin 
- 
- 
-0.678 * 
0.015 
0.178 
0.580 
PH 
Soaking 
temperature 
("c> 
Grinding 
temperature 
("c> 
Pearson 
correlation 
Sig. (2-tailed) 
Pearson 
correlation 
Sig. (2-tailed) 
Pearson 
correlation 
Sig. (2-tailed) 
Genistein 
- 
- 
0.295 
0.352 
0.818 ** 
0.001 
Daidzin 
- 
- 
-0.562 
0.057 
0.578 * 
0.049 
Daidzein 
- 
- 
-0.693 * 
0.012 
0.41 6 
0.179 
Table 9 
Pearson correlation data of isofIavone concentrations in soymilk made from beans 
soaked in HCl 
* Correlation is significant at the 0.05 level (2-tailed). 
** Correlation is significant at the 0.01 level (2-tailed). 
N = 3 6  
Processing variables Genistin 
0.138 
0.423 
0.338 * 
0.044 
0.365 * 
0.029 
pH 
Soaking 
temperature 
("c) 
Grinding 
temperature 
("c> 
Pearson 
correlation 
Sig. (2-tailed) 
Pearson 
correlation 
Sig. (2-tailed) 
Pearson 
correlation 
Sig. (2-tailed) 
Genistein 
0.092 
0.593 
-0.120 
0.485 
0.755 ** 
0.000 
Daidzin 
0.03 1 
0.858 
0.259 
0.127 
0.719** 
0.000 
Daidzein 
-0.280 
0.099 
0.133 
0.441 
0.677 ** 
0.000 
Table 10 
Pearson correlation data of isogavone concentrations in soymilk made from beans 
soaked in HC2H302 
** Correlation is significant at the 0.01 level (2-tailed). 
* Correlation is significant at the 0.05 level (2-tailed). 
N = 30 
Processing variables Genistin 
0.162 
0.393 
0.286 
0.126 
0.234 
0.214 
pH 
Soaking 
temperature 
("(3 
Grinding 
temperature 
("c) 
Pearson 
correlation 
Sig. (2-tailed) 
Pearson 
correlation 
Sig. (2-tailed) 
Pearson 
correlation 
Sig. (2-tailed) 
Genistein 
0.521 ** 
0.003 
0.1 1 1 
0.559 
0.280 
0.133 
Daidzin 
0.222 
0.239 
0.380 * 
0.038 
0.779 ** 
0.000 
Daidzein 
-0.237 
0.208 
0.010 
0.957 
0.418 * 
0.022 
Table 11 
Pair-sample t-test data 
Pair of isoflavones 
Genistin without / with 
Genistein without / with 
Daidzin without / with 
Daidzein without / with 
t 
-6.980 
-5.870 
-9.827 
-5.764 
d f 
17 
17 
17 
17 
Mean 
-.0984 
-. 1606 
-.I353 
-.I104 
Sig. 
(2-tailed) 
.OOO 
.OOO 
.OOO 
.OOO 
Differences 
S td. 
Error 
Mean 
.0141 
.0274 
.0138 
.0192 
Paired 
Std. 
Deviation 
.0598 
.I161 
.0584 
.08 13 
95% Confidence 
Interval of the 
Difference 
Lower 
-. 128 1 
-.2183 
-.I643 
-.I508 
Upper 
-.0686 
-.lo29 
-.lo62 
-.0700 
* 
Results of Research Questions 
The first question that is addressed in this study was; Is there any significant 
correlation between the pH of HCl and HC2H302 solutions and the concentrations of 
isoflavones? Since water has a constant pH at about 7, no correlation can be made as 
shown in Table 8. Table 9 shows no significant correlation between the pH of HCl 
solution and the concentrations of isoflavones. 
Table 10 shows the average concentrations of isoflavones in soymilk that were 
made by soaking the beans in HC2H302 solution at the various pH levels. The 
concentration of genistein increases with the increasing pH of HC2H302 solution. The 
mean values of genistein concentration are 0.0658 h 0.0512 mg/g at the pH of 2,0.2078 h 
0.0826 mg/g at the pH of 4, and 0.2083 h 0.0647 mg/g at the pH of 6. In Table 16, the 
only significant correlation found was between the pH of HC2H302 solution and the 
concentration of genistein. The Pearson correlation is significant at the 0.01 level 
(p < 0.01). 
The second question addressed was; Is there any significant correlation between 
the soaking temperature and the concentrations of isoflavones in soymilk made from 
soybeans were soaked in water, HCl, and HC2H302 solution? In Table 8, results from 
soymilk made from beans that were soaked in water show a negative correlation between 
soaking temperature and the concentrations of genistin and daidzein. Pearson correlation 
is significant at the level of 0.05 (p < 0.05). In Table 5b, the data show that increasing 
the soaking temperature from 5 "C to 2 1 OC results in increasing the concentrations of 
genistin and daidzein. At 5 "C the mean value of the concentration of genistin is 0.3765 h 
0.0078 mg/g and it increased to 0.4079 * 0.0243 mg/g at 21°C. The mean daidzein 
concentration at 5 "C is 0.0870 * 0.0010 mg/g and it increased to 0.1422 * 0.0147 mg/g 
at 2 1 "C. Interestingly, the concentrations of genistin and daidzein decrease from 2 1 "C to 
55 "C. The mean value of the concentration of genistin is 0.3 130 * 0.0291 mg/g at 55 "C 
and the mean value of the concentration of daidzein is 0.0087 0.0032 mg/g at 55 "C. 
Data in Table 6b show that increasing the soaking temperature from 5 "C to 55 "C 
results in increasing the concentration of genistin when soybeans were soaked in HC1 
solution. The mean value of genistin concentration is 0.3457 * 0.0261 mg/g at 5 "C, 
0.3486 * 0.0729 mg/g at 2 1 "C, and 0.3962 * 0.04.36 mg/g at 55 "C. In Table 9, the only 
significant correlation was found between the soaking temperature and the concentration 
of genistin at the 0.05 level 
(p < 0.05). 
In Table 7b, data show that increasing soaking temperature results in increasing 
concentration of daidzin when the soybeans were soaked in HC2H302 solution. The mean 
values are 0.1687 0.0296 mg/g at 5 OC, 0.2379 0.0654 mg/g at 21 "C, and 0.2413 
0.0428 mg/g at 55 "C. Table 10 shows that the only significant correlation was found 
between the soalung temperature and the concentration of daidzin at the 0.05 level 
(p < 0.05). The positive correlation indicates that the concentration of daidzin increases 
with increasing soaking temperature. 
The third question addressed in this study was; Is there any significant correlation 
between grinding temperature and the concentrations of isoflavones in soyrnilk made 
from soybeans soaked in water, HC1, and HC2H302 solutions? In Table 8, the results from 
soymilk made from beans soaked in water show significant correlation between the 
grinding temperature and the concentrations of genistein and daidzin. The data in 
Table 5c show that the mean values of the concentration of genistein are 0.1128 h 0.0658 
mg/g at 21 "C and 0.2893 h 0.0075 mglg at 80 "C. The Pearson correlation is significant 
at the level of 0.01 (p < 0.01) shown in Table 8. The mean values of the concentration of 
daidzin are 0.2003 h 0.0656 mg/g at 21 "C and 0.2883 h 0.0136 mg/g at 80 "C. The 
Pearson correlation is significant at the level of 0.05 (p < 0.05) shown in Table 8. 
In Table 6c, the results obtained from soymilk made from beans soaked in HC1 
solution show that grinding temperature strongly affects concentrations of the four 
isoflavones. The concentrations of these four isoflavones increase with the increasing 
grinding temperature. Table 9 shows significant correlations between the grinding 
temperature and concentrations of these four isoflavones. The Pearson correlations are 
significant at the level of 0.05 for the concentration of genistein (p < 0.05) and at the 
level of 0.01 for the concentrations of genistein, daidzin, and daidzein (p < 0.01). 
In Table 10, the results obtained from soymilk made from beans that were soaked 
in HC2H302 solution show that there is significant correlation between grinding 
temperature and the concentrations of daidzin and daidzein. The data in Table 7c show 
that increasing the grinding temperature results in increasing the concentrations of 
daidzin and daidzein. The mean values of the concentrations of daidzin are 0.1945 h 
0.0422 mg/g at 21 "C and 0.3 108 h 0.0158 mg/g at 80 "C. The mean values of the 
concentration of daidzein are 0.0693 h 0.0577 mg/g at 2 1 "C and 0.1322 h 0.05 13 mg/g 
at 80 "C. The positive correlation indicates that the concentrations of daidzin and 
daidzein increase with increasing grinding temperature. 
The fourth question addressed was; Does the addition of glucosidase enzyme 
affects the concentrations of isoflavones in soymilk? In other words, is there any 
significant differences in the means of isoflavone concentrations in soymilk made from 
the slurry that was treated with and without glucosidase enzyme? Table 11 shows that 
significant differences in the means of isoflavone concentrations were found in treated 
and untreated soymilk. The statistical results indicate that the addition of glucosidase 
enzyme may increase the concentrations of genistin, genistein, daidzin, and daidzein in 
producing soymilk. 
Conclusions 
The variables that were considered in this study are type and pH of soaking 
solution, soaking temperature, temperature during grinding of soybeans, and addition of 
glucosidase enzyme. The following conclusions can be drawn from this study: 
In soymilk made from beans that were soaked in water, there is an inverse 
association between the soaking temperature and the concentration of genistin and 
daidzein. In addition, a strong correlation was observed between the grinding temperature 
and the concentrations of genistein and daidzin. 
In soymilk made from the beans soaked in HCL solution, the pH of the solution 
did not affect the profile of isoflavones. However, a significant correlation was detected 
between soaking temperature and the concentration of genistin. Furthermore, the grinding 
temperature is a strong predictor of the profile of isoflavones. 
In soyrnilk made from beans soaked in HC2H302 solution, the pH of HC2H302 
solution is correlated with the concentration of genistein only. The soaking temperature 
influences the concentration of daidzin in producing soymilk. Moreover, the 
concentrations of daidzin and daidzein were also influenced by grinding temperature. 
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